Tao Qiu
Stock Analyst at Macquarie
(2.24)
# 1,430
Out of 4,479 analysts
18
Total ratings
78.57%
Success rate
-2.38%
Average return
Main Sectors:
Top Industries:
11 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BKD Brookdale Senior Living | Initiates: Outperform | $7.5 | $7.33 | +2.32% | 2 | Jun 28, 2024 | |
| PACS PACS Group | Initiates: Outperform | $35 | $29.74 | +17.69% | 1 | Jun 28, 2024 | |
| ENSG The Ensign Group | Initiates: Outperform | $134 | $125.93 | +6.41% | 3 | Jun 28, 2024 | |
| ADUS Addus HomeCare | Initiates: Outperform | $136 | $116.65 | +16.59% | 2 | Jun 28, 2024 | |
| SGRY Surgery Partners | Initiates: Outperform | $31 | $23.72 | +30.69% | 2 | Jun 28, 2024 | |
| OHI Omega Healthcare Investors | Reinstates: Buy | $35 | $33.93 | +3.15% | 1 | Jul 27, 2023 | |
| SBRA Sabra Health Care REIT | Initiates: Hold | $13 | $15.46 | -15.91% | 1 | Jul 27, 2023 | |
| CTRE CareTrust REIT | Initiates: Buy | $23 | $25.35 | -9.27% | 1 | Jul 27, 2023 | |
| PNTG The Pennant Group | Upgrades: Buy | $15 → $16 | $24.48 | -34.64% | 3 | Feb 27, 2023 | |
| EHAB Enhabit | Initiates: Buy | $17 | $8.76 | +94.06% | 1 | Dec 6, 2022 | |
| AMED Amedisys | Initiates: Hold | $128 | $96.74 | +32.31% | 1 | Jun 29, 2022 |
Brookdale Senior Living
Jun 28, 2024
Initiates: Outperform
Price Target: $7.5
Current: $7.33
Upside: +2.32%
PACS Group
Jun 28, 2024
Initiates: Outperform
Price Target: $35
Current: $29.74
Upside: +17.69%
The Ensign Group
Jun 28, 2024
Initiates: Outperform
Price Target: $134
Current: $125.93
Upside: +6.41%
Addus HomeCare
Jun 28, 2024
Initiates: Outperform
Price Target: $136
Current: $116.65
Upside: +16.59%
Surgery Partners
Jun 28, 2024
Initiates: Outperform
Price Target: $31
Current: $23.72
Upside: +30.69%
Omega Healthcare Investors
Jul 27, 2023
Reinstates: Buy
Price Target: $35
Current: $33.93
Upside: +3.15%
Sabra Health Care REIT
Jul 27, 2023
Initiates: Hold
Price Target: $13
Current: $15.46
Upside: -15.91%
CareTrust REIT
Jul 27, 2023
Initiates: Buy
Price Target: $23
Current: $25.35
Upside: -9.27%
The Pennant Group
Feb 27, 2023
Upgrades: Buy
Price Target: $15 → $16
Current: $24.48
Upside: -34.64%
Enhabit
Dec 6, 2022
Initiates: Buy
Price Target: $17
Current: $8.76
Upside: +94.06%
Amedisys
Jun 29, 2022
Initiates: Hold
Price Target: $128
Current: $96.74
Upside: +32.31%